Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Sujanu combination tablets approved in Japan

March 28, 2018

Japanese approval for Orkedia

March 27, 2018

Sanofi seeks U.S. and E.U. approval for sotagliflozin in type 1 diabetes

March 27, 2018

EMA grants PRIME designation for lumasiran in primary hyperoxaluria type 1

March 27, 2018

Amag submits NDA for bremelanotide for hypoactive sexual desire disorder

March 27, 2018

Male contraceptive 11beta-MNTDC reduces testosterone in healthy male volunteers

March 27, 2018

New indication, new formulation of Signifor LAR approved in Japan

March 26, 2018

Novel thrombopoietin receptor agonists synthesized at Sichuan Kelun-Biotech Biopharmaceutical

March 26, 2018

EMA recommends including new indication in Repatha label

March 26, 2018

Cellivery investigates leptin-targeting antiobesity therapy

March 26, 2018

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 14, 2025
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Clinical trial fraud ends with guilty pleas
BioWorld
In another real-life episode of “sponsor beware,” the owners of a clinical research facility pleaded guilty March 10 in U.S. district court to fraud charges...